Immune responses to gene therapy vectors: influence on vector function and effector mechanisms

Area of Science:

• Gene Therapy
• Immunology
• Virology

Background:

• Immune responses to viral vectors are a significant hurdle in gene therapy.
• Both innate and adaptive immunity can be triggered by viral vectors, impacting efficacy.
• Pre-existing immunity to wild-type viruses can also impede gene transfer.

Purpose of the Study:

• To review the challenges posed by immune responses to viral vectors.
• To discuss the mechanisms of innate and adaptive immunity against vectors.
• To explore strategies for circumventing vector-induced immunity.

Main Methods:

• Review of existing literature on viral vector immunogenicity.
• Analysis of innate immune responses (cytokines, chemokines) and adaptive responses (antibodies, T cells).
• Discussion of factors influencing immune responses (vector type, administration route, dose).

Main Results:

• Adenovirus vectors elicit stronger innate and adaptive immune responses compared to adeno-associated virus (AAV) vectors.
• Plasmid DNA vectors can stimulate innate immunity via TLR activation.
• Viral gene products and capsid antigens are key immunogenic components.
• Pre-existing immunity and vector administration parameters significantly affect gene transfer efficiency.

Conclusions:

• Developing strategies to overcome vector immunogenicity is essential for successful gene therapy.
• Tolerance induction, immunosuppression, and vector structural modifications are potential solutions.
• Further research is needed to optimize vector design and delivery for enhanced safety and efficacy.